Run through these tips, and we just might snag those meds without burning a hole in our pockets
Critically, this effect is glucose-dependent, meaning insulin secretion diminishes as blood glucose normalizes, substantially reducing hypoglycemia risk compared to sulfonylureas or exogenous insulin
Retatrutide remains in early research phases and is not yet FDA approved for consumer use
Researchers believe this triple-hormone approach may explain why retatrutide appears to cause more weight loss than older drugs that target only one or two of these receptors
Unlike many current weight-loss drugs that focus mainly on GLP-1 activity, retatrutide targets three hormone pathways: GIP, GLP-1, and glucagon
A Lizard's Saliva Holds a Secret Scientists studying the physiology of the Gila monster discovered that its saliva contained a unique peptide called exendin-4